RESPONSE TO RITUXIMAB TREATMENT IN MALE AND FEMALE PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS

被引：0
|
作者：
Ananyeva, Lidia
Garzanova, Liudmila
Koneva, Olga
Desinova, Oxana
Starovoytova, Mayya
Ovsyannikova, Olga
Shayakhmetova, Rushana
Khelkovskaya-Sergeeva, Anna
Babak, Valeriya
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：6405A / 6405A
页数：1
相关论文
共 50 条
  • [41] Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
    Hoffmann-Vold, Anna-Maria
    Allanore, Yannick
    Alves, Margarida
    Brunborg, Cathrine
    Airo, Paolo
    Ananieva, Lidia P.
    Czirjak, Laszlo
    Guiducci, Serena
    Hachulla, Eric
    Li, Mengtao
    Mihai, Carina
    Riemekasten, Gabriela
    Sfikakis, Petros P.
    Kowal-Bielecka, Otylia
    Riccardi, Antonella
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02) : 219 - 227
  • [42] Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients
    Sari, Alper
    Guven, Denizcan
    Armagan, Berkan
    Erden, Abdulsamet
    Kalyoncu, Umut
    Karadag, Omer
    Bilgen, Sule Apras
    Ertenli, Ihsan
    Kiraz, Sedat
    Akdogan, Ali
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (08) : 411 - 415
  • [43] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [44] Systemic sclerosis-associated interstitial lung disease
    Scallan, Ciaran J.
    Collins, Bridget F.
    Raghu, Ganesh
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 487 - 495
  • [45] Pathogenesis of systemic sclerosis associated interstitial lung disease
    Nihtyanova, Svetlana, I
    Denton, Christopher P.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2020, 5 (2_SUPPL) : 6 - 16
  • [46] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease
    Matson, S.
    Dvorkin, D.
    Fischer, A.
    Achtar-Zadeh, N.
    Wolters, P. J.
    Lee, J. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [47] DECREASE OF ANTI-TOPOISOMERASE-1 ANTIBODY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE, ASSOCIATED WITH SYSTEMIC SCLEROSIS, AS A PREDICTOR OF BETTER RESPONSE ON RITUXIMAB THERAPY
    Garzanova, Liudmila
    Ananyeva, Lidia
    Koneva, Olga
    Desinova, Oxana
    Ovsynnikova, Olga
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    CHEST, 2021, 160 (04) : 1254A - 1254A
  • [48] Systemic sclerosis-associated interstitial lung disease
    Perelas, Apostolos
    Silver, Richard M.
    Arrossi, Andrea, V
    Highland, Kristin B.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (03): : 304 - 320
  • [49] Treatment of systemic sclerosis-associated interstitial lung disease: a work in progress
    Oldham, Justin M.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (01): : 5 - 7
  • [50] Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?
    Hachulla, E.
    REVUE DE MEDECINE INTERNE, 2019, 40 (12): : 775 - 777
12345